Alvaro H Ingles Garces (Alvaro Ingles Garces)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Atomic Force Microscopy

Chemotherapy Induced

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang, Alvaro H Ingles Garces, Andrea Biondo, Ionut-Gabriel Funingana, Martin Little, Ruth Ruddle, Florence I Raynaud, Ruth Riisnaes, Bora Gurel, Sue Chua, Nina Tunariu, Joanna C Porter, Toby Prout, Mona Parmar, Anna Zachariou, Alison Turner, Ben Jenkins, Stuart McIntosh, Ed Ainscow, Anna R Minchom, Juanita Lopez, Johann S de Bono, Robert Jones, Emma C Hall, Natalie Cook, Bristi Basu, Udai Banerji
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquin Mateo, Jessica S Brown, Alvaro H Ingles Garces, Ruth Ruddle, Shaun Decordova, Simone Jueliger, Roberta Ferraldeschi, Oscar Maiques, Victoria Sanz-Moreno, Paul Jones, Stephanie Traub, Gavin W Halbert, Sarah Mellor, Karen E Swales, Florence I Raynaud, Michelle D Garrett, Udai Banerji
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Alvaro H Ingles Garces, Lewis Au, Robert Mason, Jennifer Thomas, James Larkin
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer. Expert opinion on investigational drugs 28 (8) (2019)